Skip to main content
NIH funding notice PAR-18-683

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)

Closed on January 7, 2021.

Posted
February 27, 2018
Close date
January 7, 2021
Activity codes
R61, R33
Institutes taking part
NHLBI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-21-119.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,518,421 in first-year total cost, median $415,514.

Most frequent study sections

  1. Special Emphasis Panel[ZHL1 CSR-B (F3)]1
  2. Special Emphasis Panel[ZHL1 CSR-B (M1)]1
  3. Special Emphasis Panel[ZHL1 CSR-H (F1)]1
  4. Special Emphasis Panel[ZHL1 CSR-H (F2)]1
  5. Special Emphasis Panel[ZHL1 CSR-H (M1)]1

Most frequent institutions

  1. WEILL MEDICAL COLL OF CORNELL UNIV2
  2. CINCINNATI CHILDRENS HOSP MED CTR1
  3. DUKE UNIVERSITY1
  4. UNIV OF MASSACHUSETTS MED SCH WORCESTER1
  5. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PAR-18-683 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation1R61HL158541-01DONAHUE, J KEVINMCMANUS, DAVID D.UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA$418,750ZHL1
2021Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)1R61HL156888-01KRISCHER, JEFFREY PTRAPNELL, BRUCE CCINCINNATI CHILDRENS HOSP MED CTR, OH$410,607ZHL1
2020A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS1R61HL153011-01CHOI, AUGUSTINE MFREDENBURGH, LAURA ELIZABETHWEILL MEDICAL COLL OF CORNELL UNIV, NY$452,945ZHL1
2020Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia1R61HL151355-01CRYSTAL, RONALD GKAMINSKY, STEPHEN MICHAELWEINSAFT, JONATHAN W.WEILL MEDICAL COLL OF CORNELL UNIV, NY$420,378ZHL1
2019Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia1R61HL147833-01HORNIK, CHRISTOPHLAUGHON, MATTHEWDUKE UNIVERSITY, NC$412,278ZHL1
2019Developing Oral LT3 Therapy for Heart Failure1R61HL146390-01CAPPOLA, ANNE RCAPPOLA, THOMAS P.CHIRINOS MEDINA, JULIO ALONSOUNIVERSITY OF PENNSYLVANIA, PA$403,463ZHL1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-683: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) | ScienceDex | ConductScience